SPY002-072

· Spyre Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPY002-072, covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPY002-072 in Healthy Volunteers [Phase 1]